Veena S. John

Veena John practices at Schlanger, Gottlieb Partners Council Breast Imaging Center in Lake Success, New York.

Veena John's NPI, 1356475610, was assigned on March 16, 2007. Veena John graduated from Christian Medical College Ludhiana in 1992. Veena John holds New York license 214898.

Veena John's primary practice is Schlanger, Gottlieb Partners Council Breast Imaging Center, at 450 Lakeville Rd, Lake Success, NY 11042. The practice phone is (516) 734-8281.

Veena John's primary practice is Schlanger, Gottlieb Partners Council Breast Imaging Center in Lake Success, New York. Veena John is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Veena John to 2 more hospitals, 2 group practices and clinics, 1 clinical lab, 1 home health agency, 1 hospice and 1 medical group, each named with a free account. Veena John's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Veena John practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Veena John's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Veena John is licensed in New York.

CMS data shows 1,562 Medicare services from Veena John across 7 procedure codes in 2024, for 343 Medicare patients. Medicare paid $132,987 for them.

CMS counts 343 Medicare patients who saw Veena John in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Veena John's median patient age at 74, with 95% women.

In 2024, Veena John wrote 757 Medicare Part D claims for 201 patients. 81% of them were for generic drugs. CMS names the drug for 616 of them, across 15 drugs with 11 or more claims each, at $1,232,059 in total drug cost. In 2023, CMS named 236 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Veena John for performance year 2024, reported as part of a group. Veena John accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Veena John as offering telehealth.

Dmand AI links 21 papers to Veena John, published from 2013 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Ovarian Neoplasms, Antibodies, Monoclonal, Humanized and Antineoplastic Combined Chemotherapy Protocols. Veena John has published most often in Cureus. Veena John's most frequent co-authors are Lisa M. Landrum, MD, Premal Harish Thaker, MD and Carol Aghajanian, MD.

Dmand AI links Veena John to 11 clinical trials, 5 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Ovarian Epithelial, Fallopian Tube Diseases and Ovarian Neoplasms. National Cancer Institute (NCI) sponsors the most, 4. Open Payments lists research payments to Veena John that name 1 trial.

CMS Open Payments shows 35 general payments to Veena John from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 93% of the total. AstraZeneca Pharmaceuticals LP paid the most, $20,028. It also lists 6 research payments totaling $15,601 in 2017, naming 1 clinical trial.

Veena John graduated from Christian Medical College Ludhiana in 1992.